HK1073997A1
(en )
2005-10-28
Administration of agents for the treatment of inflammation
IL196301A0
(en )
2009-09-22
Medicament for the treatment of hapatitis c
GB9925136D0
(en )
1999-12-22
Novel treatment
HUP0200738A3
(en )
2003-03-28
Method of the treatment of incontinence
AU5056099A
(en )
2000-02-14
Compounds for use in the treatment of inflammation
PL349347A1
(en )
2002-07-15
Novel treatment
IL133760A0
(en )
2001-04-30
Composition for the treatment of dandruff
IL155769A0
(en )
2003-12-23
Method for the treatment of inflammation
HUP0105310A2
(en )
2002-06-29
Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
AU7653600A
(en )
2001-04-30
Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
HUP0001891A3
(en )
2003-07-28
Medicament for the treatment of migraine
AU2566201A
(en )
2001-07-09
Compounds and methods for the treatment of pain
GB9904252D0
(en )
1999-04-21
Composition for the treatment of pain
SI1150704T1
(en )
2006-08-31
Melagatran for the treatment of inflammation
AU2504101A
(en )
2001-06-04
Device for carrying out the oscillation-induced selective treatment of malignantdiseases
IL150208A0
(en )
2002-12-01
Compound and method for the treatment of pain
AU2420201A
(en )
2001-07-09
Compounds and methods for the treatment of pain
AU5756199A
(en )
2001-05-10
Installation for magnetotherapy treatment
GB9908993D0
(en )
1999-06-16
Treatment
GB9923343D0
(en )
1999-12-08
Treatment system
GB9910545D0
(en )
1999-07-07
The treatment of acarids
GB9918000D0
(en )
1999-09-29
Compositions for the treatment of pain
AUPP866799A0
(en )
1999-03-11
Treatment apparatus
AUPQ305099A0
(en )
1999-10-21
Side effects treatment
AUPQ406499A0
(en )
1999-12-09
Side effects treatment